James Frew Increases Customer Appointment Completion Rates with Descartes’ Customer Engagement Platform
Globe Newswire23-07-2024, 17:45
Teva Prolia® (Denosumab) Biosimilar Candidate is Accepted for Review by U.S. FDA and EU EMA 8-10-2024, 18:00
23-07-2024, 17:45
